ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Copy-number variants and polygenic risk for intelligence confer risk for autism spectrum disorder irrespective of their effects on cognitive ability

Schmilovich, Zoe; Bourque, Vincent-Raphael; Douard, Elise; Huguet, Guillaume; Poulain, Cecile; Ross, Jay P.; Alipour, Paria; Castonguay, Charles-Etienne; Younis, Nadine; Jean-Louis, Martineau; Saci, Zohra; Pausova, Zdenka; Paus, Tomas; Schuman, Gunter; Porteous, David; Davies, Gail; Redmond, Paul; Harris, Sarah E.; Deary, Ian J.; Whalley, Heather; Hayward, Caroline; Dion, Patrick A.; Jacquemont, Sebastien; Rouleau, Guy A.*
Frontiers in Psychiatry2024-5-1DOI: 10.3389/fpsyt.2024.1369767
5阅读
引用收藏
分享

摘要

Introduction Rare copy number variants (CNVs) and polygenic risk for intelligence (PRS-IQ) both confer susceptibility for autism spectrum disorder (ASD) but have opposing effects on cognitive ability. The field has struggled to disentangle the effects of these two classes of genomic variants on cognitive ability from their effects on ASD susceptibility, in part because previous studies did not include controls with cognitive measures. We aim to investigate the impact of these genomic variants on ASD risk while adjusting for their known effects on cognitive ability.Methods In a cohort of 8,426 subjects with ASD and 169,804 controls with cognitive assessments, we found that rare coding CNVs and PRS-IQ increased ASD risk, even after adjusting for their effects on cognitive ability.Results Bottom decile PRS-IQ and CNVs both decreased cognitive ability but had opposing effects on ASD risk. Models combining both classes of variants showed that the effects of rare CNVs and PRS-IQ on ASD risk and cognitive ability were largely additive, further suggesting that susceptibility for ASD is conferred independently from its effects on cognitive ability. Despite imparting mostly additive effects on ASD risk, rare CNVs and PRS-IQ showed opposing effects on core and associated features and developmental history among subjects with ASD.Discussion Our findings suggest that cognitive ability itself may not be the factor driving the underlying liability for ASD conferred by these two classes of genomic variants. In other words, ASD risk and cognitive ability may be two distinct manifestations of CNVs and PRS-IQ. This study also highlights the challenge of understanding how genetic risk for ASD maps onto its dimensional traits.

学科与关键词

关键词
CNV (copy number variant)polygenic risk score (PRS)ASD autism spectrum disorderscognitive abilitiesintelligence quotient (IQ)
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Psychiatry
发表日期
2024-05-01
卷期
第 15 卷
页码
1369767
DOI
10.3389/fpsyt.2024.1369767
成果收录
SCIE
资助标注
Canadian Institutes of Health Research (CIHR) Frederick Banting & Charles Best Canada Graduate Scholarship; Transforming Autism Care Consortium; ALS Society of Canada; CIHR Frederick Banting & Charles Best Canada Graduate Scholarship [FRN159279]; Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6]; Scottish Funding Council [HR03006]; Wellcome Trust [104036/Z/14/Z]; Medical Research Council UK; European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behaviour in normal brain function and psychopathology) [LSHM-CT- 2007-037286, 695313]; Human Brain Project [785907, 945539]; Medical Research Council Grant 'c-VEDA' (Consortium on Vulnerability to Externalizing Disorders and Addictions) [MR/N000390/1]; National Institute of Health (NIH) [R01DA049238]; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; Bundesministeriumfr Bildung und Forschung (BMBF) [01GS08152, 01EV0711]; Forschungsnetz [AERIAL 01EE1406A, 01EE1406B, IMAC-Mind 01GL1745B]; Deutsche Forschungsgemeinschaft (DFG) [SM 80/7-2, SFB 940, TRR 265, NE 1383/14-1]; Medical Research Foundation and Medical Research Council [MR/R00465X/1, MR/S020306/1]; National Institutes of Health (NIH) [5U54EB020403-05, 1R56AG058854-01]; ANR [ANR-12-SAMA-0004]; Eranet Neuron [AF12-NEUR0008-01 - WM2NA, ANR-18-NEUR00002-01 - ADORe]; Fondation de France [00081242, DPA20140629802]; Mission Interministrielle de Lutte-contre-les-Drogues-et-les-Conduites-Addictives (MILDECA); INSERM (interface grant), Paris Sud University IDEX [AP-RM-17-013]; National Institutes of Health, Science Foundation Ireland (16/ERCD/3797), U.S.A. (Axon, Testosterone and Mental Health) [RO1 MH085772-01A1]; NIH Consortium [U54 EB020403, LBC1936]; Biotechnology and Biological Sciences Research Council; Economic and Social Research Council [BB/W008793/1]; Age UK (Disconnected Mind project); Milton Damerel Trust; Univ

作者

  • S

    Schmilovich, Zoe (第一作者)

  • B

    Bourque, Vincent-Raphael

查看全部 24 位作者收起作者
  • D

    Douard, Elise

  • H

    Huguet, Guillaume

  • P

    Poulain, Cecile

  • R

    Ross, Jay P.

  • A

    Alipour, Paria

  • C

    Castonguay, Charles-Etienne

  • Y

    Younis, Nadine

  • J

    Jean-Louis, Martineau

  • S

    Saci, Zohra

  • P

    Pausova, Zdenka

  • P

    Paus, Tomas

  • S

    Schuman, Gunter

  • P

    Porteous, David

  • D

    Davies, Gail

  • R

    Redmond, Paul

  • H

    Harris, Sarah E.

  • D

    Deary, Ian J.

  • W

    Whalley, Heather

  • H

    Hayward, Caroline

  • D

    Dion, Patrick A.

  • J

    Jacquemont, Sebastien

  • R

    Rouleau, Guy A. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417